BOSTON SCIENTIFIC CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.25 USD | +0.47% |
|
+8.65% | +26.71% |
| 05:08pm | UBS Raises Boston Scientific's Price Target to $90 From $74, Maintains Buy Rating | MT |
| 04:28pm | Oppenheimer Adjusts Boston Scientific's Price Target to $77 From $68 | MT |
Presenter SpeechJoanne Wuensch (Analysts)So everybody, welcome, and good morning. I'm Joanne W...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Calendar
2024-05-02
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
72.91
USD
Average target price
78.18
USD
Spread / Average Target
+7.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +26.71% | 107B | |
| +7.98% | 220B | |
| +6.92% | 185B | |
| +10.06% | 133B | |
| -0.57% | 62.91B | |
| +15.46% | 53.34B | |
| -1.89% | 47.71B | |
| -2.06% | 40.29B | |
| +10.02% | 39.57B | |
| +5.57% | 26.99B |
- Stock Market
- Equities
- BSX Stock
- News Boston Scientific Corporation
- Transcript : Boston Scientific Corporation Presents at Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference, Mar-01-2023 08
